A study and accompanying editorial from the Journal of Clinical Oncology found that Hodgkin lymphoma survivors still face a higher risk of non-cancer death than the general population.
Rose McNulty
Advertisement
Rose is an associate editorial director at The American Journal of Managed Care® (AJMC®).
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Articles by Rose McNulty
Findings suggest that current standard treatment does not eliminate the risk of breast cancer-specific death in the 20 years after DCIS diagnosis.
Natera’s Signatera ctDNA test will determine study eligibility and treatment effectiveness in HR-positive, HER2-negative breast cancer patients.
Research from the American Cancer Society suggests that more young people are being introduced to nicotine via e-cigarettes.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Increased Risk of Recurrence in NSCLC Found After Preoperative PTNB
2
Accountable Care: Not Just for the Healthiest Patients
3
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
4
Novel Machine Learning Model Improves MASLD Detection in Type 2 Diabetes
5
